542 related articles for article (PubMed ID: 25973681)
1. Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner.
Werthmöller N; Frey B; Wunderlich R; Fietkau R; Gaipl US
Cell Death Dis; 2015 May; 6(5):e1761. PubMed ID: 25973681
[TBL] [Abstract][Full Text] [Related]
2. Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo.
Werthmöller N; Frey B; Rückert M; Lotter M; Fietkau R; Gaipl US
Int J Hyperthermia; 2016; 32(1):23-30. PubMed ID: 26754406
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
[TBL] [Abstract][Full Text] [Related]
4. Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth.
Hervieu A; Rébé C; Végran F; Chalmin F; Bruchard M; Vabres P; Apetoh L; Ghiringhelli F; Mignot G
J Invest Dermatol; 2013 Feb; 133(2):499-508. PubMed ID: 22951720
[TBL] [Abstract][Full Text] [Related]
5. [Anti-tumor effect of cisplatin combined with DC vaccine on tumor-bearing mice].
You HY; Lian WG; Zhang HL; Wang JX; Zhang KX; Song SX
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):336-40. PubMed ID: 22883452
[TBL] [Abstract][Full Text] [Related]
6. Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response.
Zhang X; Niedermann G
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):63-73. PubMed ID: 29534901
[TBL] [Abstract][Full Text] [Related]
7. The Caspase Inhibitor Z-VAD-FMK Alleviates Endotoxic Shock via Inducing Macrophages Necroptosis and Promoting MDSCs-Mediated Inhibition of Macrophages Activation.
Li X; Yao X; Zhu Y; Zhang H; Wang H; Ma Q; Yan F; Yang Y; Zhang J; Shi H; Ning Z; Dai J; Li Z; Li C; Su F; Xue Y; Meng X; Dong G; Xiong H
Front Immunol; 2019; 10():1824. PubMed ID: 31428103
[TBL] [Abstract][Full Text] [Related]
8. zVAD-fmk upregulates caspase-9 cleavage and activity in etoposide-induced cell death of mouse embryonic fibroblasts.
Rodríguez-Enfedaque A; Delmas E; Guillaume A; Gaumer S; Mignotte B; Vayssière JL; Renaud F
Biochim Biophys Acta; 2012 Aug; 1823(8):1343-52. PubMed ID: 22613767
[TBL] [Abstract][Full Text] [Related]
9. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
[TBL] [Abstract][Full Text] [Related]
10. The contraction phase of virus-specific CD8+ T cells is unaffected by a pan-caspase inhibitor.
Nussbaum AK; Whitton JL
J Immunol; 2004 Dec; 173(11):6611-8. PubMed ID: 15557151
[TBL] [Abstract][Full Text] [Related]
11. Caspase inhibitor zVAD-fmk protects against acute pancreatitis-associated lung injury via inhibiting inflammation and apoptosis.
Liu M; Shi L; Zou X; Zheng X; Zhang F; Ding X; Zhu H; Shen Y
Pancreatology; 2016; 16(5):733-8. PubMed ID: 27324074
[TBL] [Abstract][Full Text] [Related]
12. Yersinia YopP-induced apoptotic cell death in murine dendritic cells is partially independent from action of caspases and exhibits necrosis-like features.
Gröbner S; Autenrieth SE; Soldanova I; Gunst DS; Schaller M; Bohn E; Müller S; Leverkus M; Wesselborg S; Autenrieth IB; Borgmann S
Apoptosis; 2006 Nov; 11(11):1959-68. PubMed ID: 17036200
[TBL] [Abstract][Full Text] [Related]
13. Pan-caspase inhibitors induce necroptosis via ROS-mediated activation of mixed lineage kinase domain-like protein and p38 in classically activated macrophages.
Koike A; Hanatani M; Fujimori K
Exp Cell Res; 2019 Jul; 380(2):171-179. PubMed ID: 31039349
[TBL] [Abstract][Full Text] [Related]
14. zVAD-fmk, unlike BocD-fmk, does not inhibit caspase-6 acting on 14-3-3/Bad pathway in apoptosis of p815 mastocytoma cells.
Yee SB; Baek SJ; Park HT; Jeong SH; Jeong JH; Kim TH; Kim JM; Jeong BK; Park BS; Kwon TK; Yoon I; Yoo YH
Exp Mol Med; 2006 Dec; 38(6):634-42. PubMed ID: 17202839
[TBL] [Abstract][Full Text] [Related]
15. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.
Wack C; Kirst A; Becker JC; Lutz WK; Bröcker EB; Fischer WH
Cancer Immunol Immunother; 2002 Oct; 51(8):431-9. PubMed ID: 12202904
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated radiotherapy combined with lenalidomide improves systemic antitumor activity in mouse solid tumor models.
Onyshchenko K; Luo R; Rao X; Zhang X; Gaedicke S; Grosu AL; Firat E; Niedermann G
Theranostics; 2024; 14(6):2573-2588. PubMed ID: 38646638
[No Abstract] [Full Text] [Related]
17. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
Yin W; Song Y; Liu Q; Wu Y; He R
Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
[TBL] [Abstract][Full Text] [Related]
18. Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development.
McLellan AD; Terbeck G; Mengling T; Starling GC; Kiener PA; Gold R; Bröcker EB; Leverkus M; Kämpgen E
Cell Death Differ; 2000 Oct; 7(10):933-8. PubMed ID: 11279539
[TBL] [Abstract][Full Text] [Related]
19. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.
Fujii S; Shimizu K; Smith C; Bonifaz L; Steinman RM
J Exp Med; 2003 Jul; 198(2):267-79. PubMed ID: 12874260
[TBL] [Abstract][Full Text] [Related]
20. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
